Attached files

file filename
10-K - 10-K - ANI PHARMACEUTICALS INCa11-7481_110k.htm
EX-32.1 - EX-32.1 - ANI PHARMACEUTICALS INCa11-7481_1ex32d1.htm
EX-31.1 - EX-31.1 - ANI PHARMACEUTICALS INCa11-7481_1ex31d1.htm
EX-10.4 - EX-10.4 - ANI PHARMACEUTICALS INCa11-7481_1ex10d4.htm
EX-31.2 - EX-31.2 - ANI PHARMACEUTICALS INCa11-7481_1ex31d2.htm
EX-10.3 - EX-10.3 - ANI PHARMACEUTICALS INCa11-7481_1ex10d3.htm
EX-10.30 - EX-10.30 - ANI PHARMACEUTICALS INCa11-7481_1ex10d30.htm
EX-10.28 - EX-10.28 - ANI PHARMACEUTICALS INCa11-7481_1ex10d28.htm
EX-10.31 - EX-10.31 - ANI PHARMACEUTICALS INCa11-7481_1ex10d31.htm
EX-10.33 - EX-10.33 - ANI PHARMACEUTICALS INCa11-7481_1ex10d33.htm
EX-10.27 - EX-10.27 - ANI PHARMACEUTICALS INCa11-7481_1ex10d27.htm
EX-10.14 - EX-10.14 - ANI PHARMACEUTICALS INCa11-7481_1ex10d14.htm
EX-10.32 - EX-10.32 - ANI PHARMACEUTICALS INCa11-7481_1ex10d32.htm
EX-32.2 - EX-32.2 - ANI PHARMACEUTICALS INCa11-7481_1ex32d2.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement Nos. 333-168842, 333-151660, 333-151663, 333-109474, 333-100238 and 333-53384 on Form S-8 and in Registration Statement Nos. 333-156276, 333-166859, 333-159606, 333-144665, 333-136852, and 333-64218 on Form S-3 of our reports dated March 16, 2011, relating to the financial statements of BioSante Pharmaceuticals, Inc., and the effectiveness of BioSante Pharmaceuticals Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of BioSante Pharmaceuticals, Inc. for the year ended December 31, 2010.

 

/s/ DELOITTE & TOUCHE LLP

 

Chicago, Illinois

March 16, 2011